This section is not available in the published analysis.
BioMarin Pharmaceutical Inc.: Audience
BioMarin is a global biotechnology company that develops innovative medicines to treat serious genetic conditions. Their portfolio includes treatments for achondroplasia, severe hemophilia A, and various rare inherited diseases.